Essilor International (ESLOY) Stock Rating Upgraded by Zacks Investment Research

Essilor International (OTCMKTS:ESLOY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday.

According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “

Separately, Royal Bank of Canada initiated coverage on shares of Essilor International in a report on Thursday, September 21st. They set an “underperform” rating on the stock.

Shares of Essilor International (ESLOY) opened at $69.13 on Tuesday. Essilor International has a fifty-two week low of $54.00 and a fifty-two week high of $68.62. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.09 and a quick ratio of 0.76.

TRADEMARK VIOLATION NOTICE: This report was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://www.com-unik.info/2017/12/28/essilor-international-esloy-stock-rating-upgraded-by-zacks-investment-research.html.

About Essilor International

Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is a France-based ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories and instruments, and services for eye care professionals.

What are top analysts saying about Essilor International? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Essilor International and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit